Drug intelligence / Profile preview

oxymorphone

Development stage
Approved
Lead developer
Endo International
Modality
Small Molecules
Administration
Oral, Intravenous, Intramuscular
01

Overview

Oxymorphone is a potent opioid analgesic used for the management of moderate to severe pain, particularly in patients who require an opioid and for whom alternative treatments are inadequate. It is available as immediate-release and extended-release oral tablets, as well as injectable formulations. Oxymorphone acts primarily as a selective agonist at the mu-opioid receptor in the central nervous system, altering pain perception and response. At higher doses, it may interact with other opioid receptors. The drug is more lipophilic than morphine, allowing easier penetration of the blood-brain barrier. Oxymorphone has no significant interactions with major cytochrome P450 enzymes (CYP3A4, CYP2C9, CYP2D6), reducing its potential for certain drug-drug interactions[1][2][5][7].

Brand names
OpanaOpana ERNumorphan
Other names
14-hydroxydihydromorphinone
02

Targets

MOR (Mu opioid receptor)

Beyond the preview

Go deeper on oxymorphone.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on oxymorphone.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call